Emerging Markets to Revive and Boost the Global Pharma Industry
On the back of increasing healthcare expenditure and numerous reform measures by the governments of emerging markets, the global pharma market is projected to grow at a CAGR of 6.5% by 2013.
- (1888PressRelease) February 07, 2011 - Our study, "Global Pharmaceutical Market Forecast to 2012" reveals that the pharmaceutical market worldwide, after experiencing a slump during the past 2 years, is now in its recovery period, which will be followed by its growth. Decline in the global pharma market was largely due to the economic slowdown. However, the market is recovering now and the US remains at the top position globally, followed by the European Union and Japan.
It is expected that future growth of the industry will be propelled by the emerging markets, including the Asia-Pacific, Latin America, and Central and Eastern European markets. We project that the global pharma market will grow at a CAGR of around 6.5% during 2011-2013.
Despite facing challenges, the pharmaceutical market in the developing nations is growing at a fast pace. This can be attributed to the untapped potential of nations such as, India, China, Brazil, Russia, Turkey, Poland, Indonesia, Vietnam, and others. Considering the reform measures being taken by various countries regarding control of drug counterfeiting and trade channels, pharma giants are looking at these markets for their expansion. Besides, issues of IPR and healthcare spending are also being resolved and is expected to boost the pharma industry overall.
As part of their expansion strategy in emerging markets, big companies are opting for mergers & acquisitions of local companies. Besides, focus of the companies has now shifted to niche therapy areas and preventive medication. Our report deeply analyzes the major regions of the world and the most promising markets comprised by them. There is also a clear assessment of leading therapy classes, drugs, and competitive analysis of the key players in the industry.
Our report has identified North America, Latin America, Europe, Asia-Pacific and Africa as the most important regions to be looked out for in the global pharma market. The report contains statistical and analytical information on each of these markets, covering their current market size, demand, and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM149.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS:
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
###
space
space
Contact Information
- Shushmul Maheshwari
- Rncos
- B 129 Sector 6
- Noida 201301
- 201301
- Voice: 91-120-4224-700
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam